Recently, triple-negative breast cancer (TNBC) has been classified as a breast cancer subgroup that is negative for estrogen and progesterone receptors (ER/PR) and receptor 2 of human epidermal growth factor (HER2). Here, PGR is linked to triple-negative breast carcinoma.